DexCom (DXCM) Revenue — Quarter Ended Mar 31, 2025
Revenue for the quarter remained at the same level as the prior quarter, but increased compared with the same quarter one year earlier. The year-over-year growth continued a long-running trend of rising revenue.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue for the quarter remained at the same level as the prior quarter, but increased compared with the same quarter one year earlier. The year-over-year growth continued a long-running trend of rising revenue.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1B
Revenue reported for this quarter.
Quarter-over-quarter
-7.0%
Change from the immediately preceding quarter.
Year-over-year
+12.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $1B | +15.3% |
| Sep 30, 2024 | $994.2M | +2.0% |
| Dec 31, 2024 | $1.1B | +7.6% |
| Mar 31, 2025 | $1B | +12.5% |
Revenue performance
Reported revenue was unchanged from the immediately preceding quarter, indicating a stabilization in the top line after several quarters of sequential gains. Sequentially, the prior quarter had shown growth, so the flattening represents a pause in the upward trajectory.
Quarterly comparison
Compared with the same quarter one year earlier, revenue showed a solid increase. That year-over-year improvement was larger than the sequential change, highlighting strong annual demand.
What to watch
Revenue has plateaued on a sequential basis; watch for whether this level is maintained or if momentum resumes in the coming quarter.